Operating Income - Sesen Bio Inc (F:PCBK) - Alpha Spread
S

Sesen Bio Inc
F:PCBK

Watchlist Manager
Sesen Bio Inc
F:PCBK
Watchlist
Price: 0.5124 EUR 28.1%
Market Cap: 103.9m EUR
Have any thoughts about
Sesen Bio Inc?
Write Note

Sesen Bio Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sesen Bio Inc
Operating Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Sesen Bio Inc
F:PCBK
Operating Income
$13.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Operating Income
$16B
CAGR 3-Years
-1%
CAGR 5-Years
5%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Operating Income
$10.3B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Operating Income
$6.2B
CAGR 3-Years
-11%
CAGR 5-Years
-9%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Income
$4.2B
CAGR 3-Years
23%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Income
$4.2B
CAGR 3-Years
-14%
CAGR 5-Years
14%
CAGR 10-Years
17%

See Also

What is Sesen Bio Inc's Operating Income?
Operating Income
13.6m USD

Based on the financial report for Dec 31, 2022, Sesen Bio Inc's Operating Income amounts to 13.6m USD.

What is Sesen Bio Inc's Operating Income growth rate?
Operating Income CAGR 1Y
-53%

Over the last year, the Operating Income growth was -53%.

Back to Top